Getting Started

[rando2]

Are you looking for a way to contribute? Great, we're happy to have you!

We'll comment below with the most up-to-date information about where help is needed.

As a note, here is some information about how to get started using GitHub

[rando2]

Current ways to contribute:

1. Introduce yourself at Introduce yourself here first! #17
2. Contribute to a discussion or call for help
3. Use the New Paper Template to propose a paper you think should be read for the review. Please use the New Paper Template for background papers and reviews. For papers describing diagnostics, use the New Diagnostic Template. For papers describing Therapeutics, use the New Therapeutic Template.
4. Propose changes to the Introduction or to the current outlines of the Pathogenesis, Diagnostics and Therapeutics sections of the paper
5. Don't see something you think is important or have a question? Open a new issue and start a conversation!
6. Chat with other contributors on gitter

[rando2]

Steps for Suggesting a Paper:

1. Choose a paper
2. Search for the title or DOI in Issues.
3. If paper is not already discussed, open a new issue for it. Otherwise, contribute to the discussion on the issue for that paper.
4. In the issue, fill out the template with the available information from the paper (some papers may not have information for all the items, which could be noted as a limitation)

(Suggestion & initial draft by @SiminaB , edited by @agitter )

[rando2]

Commenting on a Pull Request

Commenting on a pull request will let you give feedback on text that has been submitted.

See here for text we're looking for feedback on.

You can follow this guide for adding your comments and edits.

Use the labels to filter by subject areas (pharmacology, immunology, etc.)

[rando2]

Questions to Think About
From @dziakj1:

Hello everybody! I was watching a lecture on Youtube from Dr. Britt Glaunsinger of Berkeley:
https://www.youtube.com/watch?v=8_bOhZd6ieM
At the end (about 1:00:00), she listed six questions which she considered especially important for future basic science research on SARS-CoV-2:

1. "What is the role of the polybasic site in the spike protein in CoV-2 transmission?"
2. "What are the pathways involved in CoV-induced memberane remodeling, and how do RTCs temporally and functionally coordinate various stages of the viral lifecycle?"
3. "What are the biochemical activities and roles of the various proteins that form the replication transcription complex, and how do they coordinate genome replication vs. transcription?"
4. "How do CoVs maintain such a large genome and still have sufficient mutation rates for adaptation and trans-species movement?"
5. "What are the functions of the CoV-2 accessory proteins, and how do they impact the in vivo growth and virulence of the virus?"
6. "Will CoV-2 infected individuals (or vaccines) mount protective long-term immune responses?"
   I just wanted to pass this along in case it gave anyone any useful ideas on what topics to focus on in reviewing.

[dziakj1]

Hello everybody! In case anyone missed it, a narrative review of pharmacological treatments for COVID-19 just came out in JAMA: https://jamanetwork.com/journals/jama/fullarticle/2764727

[dziakj1]

This new curated and annotated resource from Kathryn Grabowski at Johns Hopkins (@JHU_NCRC on Twitter) looks extremely promising:
Novel Coronavirus Research Compendium
https://docs.google.com/spreadsheets/d/e/2PACX-1vRpGhzDhyroswkqKMR9YkxtueVDq7hLjQuDMlsxjrBt8iLyJnZGu7NvBzawB_aNTnhq7ALuhxA1-wMc/pubhtml
They say they will launch a website (not just a Google doc) very soon.

[rando2]

A great thing to do is to go through @rdvelazquez list of preprints that need issues opened in #227
Use the appropriate New Paper template to open an issue for the papers and then comment on #227 saying which papers you created issues for

[rando2]

Key questions to think about: https://www.idsociety.org/globalassets/idsa/public-health/covid-19/idsa-covid-19-key-research-qs.pdf